- Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial
- Eicosapentaenoic acid reduces fecal levels of calprotectin and prevents relapse in patients with ulcerative colitis
- Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: Results from the German RABBIT cohort
- Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: Phase 2 clinical KEYNOTE-059 trial
- Biosimilar vs originator insulins: Systematic review and meta-analysis
- Administering atropine and ketamine before less invasive surfactant administration resulted in low pain scores in a prospective study of premature neonates
- The safety and effectiveness profile of eldecalcitol in a prospective, post-marketing observational study in Japanese male patients with osteoporosis
- Adverse drug events associated with low-dose (10 mg) vs high-dose (25 mg) empagliflozin in patients treated for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
- Adalimumab treatment of anti-TNF-naive patients with ulcerative colitis: Deep remission and response factors
- Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion: A randomized clinical trial
- Effects of denosumab on bone mineral density in Japanese women with osteoporosis treated with aromatase inhibitors for breast cancer
- Adalimumab reduces extraintestinal manifestations in patients with Crohn's disease: A pooled analysis of 11 clinical studies
- Effects of adjunctive N-acetylcysteine on depressive symptoms: Modulation by baseline high-sensitivity C-reactive protein
- Association of mental health conditions and treatments with long-term opioid analgesic receipt among adolescents
- Long-term efficacy of reduced-intensity vs myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: Retrospective follow-up of an open-label, randomised phase 3 trial
Feed Sources
